186 related articles for article (PubMed ID: 14969090)
21. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
Pajic B; Pajic-Eggspuehler B; Häfliger IO
Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
[TBL] [Abstract][Full Text] [Related]
22. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
23. The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
Stewart WC; Stewart JA; Day DG; Jenkins J
Acta Ophthalmol Scand; 2004 Apr; 82(2):161-5. PubMed ID: 15043534
[TBL] [Abstract][Full Text] [Related]
24. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
Stewart WC; Sharpe ED; Stewart JA; Holmes KT; Latham KE
Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
[TBL] [Abstract][Full Text] [Related]
25. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
Toris CB; Zhan G; Camras CB
Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
[TBL] [Abstract][Full Text] [Related]
26. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
27. Rescula as an alternative therapy for beta-blockers with long-term drift effect in glaucoma patients.
Chen CL; Tseng HY; Wu KY
Kaohsiung J Med Sci; 2006 Jun; 22(6):266-70. PubMed ID: 16793563
[TBL] [Abstract][Full Text] [Related]
28. Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patients.
Kimura I; Shinoda K; Tanino T; Ohtake Y; Mashima Y
Jpn J Ophthalmol; 2005; 49(4):287-93. PubMed ID: 16075327
[TBL] [Abstract][Full Text] [Related]
29. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
[TBL] [Abstract][Full Text] [Related]
30. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
[TBL] [Abstract][Full Text] [Related]
31. Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone.
Enoki M; Saito J; Hara M; Uchida T; Sagara T; Nishida T
Jpn J Ophthalmol; 2006; 50(4):334-337. PubMed ID: 16897217
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
[TBL] [Abstract][Full Text] [Related]
33. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
Messmer C; Flammer J; Stümpfig D
Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
[TBL] [Abstract][Full Text] [Related]
34. Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma.
Collignon-Brach J
Curr Eye Res; 1992 Jan; 11(1):1-3. PubMed ID: 1559386
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
36. Longterm visual field follow-up of glaucoma patients treated with beta-blockers.
Kaiser HJ; Flammer J; Stümpfig D; Hendrickson P
Surv Ophthalmol; 1994 May; 38 Suppl():S156-9; discussion S160. PubMed ID: 7940137
[TBL] [Abstract][Full Text] [Related]
37. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
38. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
39. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.
Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE;
J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
